Compare SJM & PEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SJM | PEN |
|---|---|---|
| Founded | 1897 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.6B | 12.8B |
| IPO Year | 1994 | 2015 |
| Metric | SJM | PEN |
|---|---|---|
| Price | $96.84 | $323.80 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 16 |
| Target Price | $115.85 | ★ $360.14 |
| AVG Volume (30 Days) | ★ 1.6M | 460.7K |
| Earning Date | 06-09-2026 | 05-12-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ 1155.56 |
| EPS | N/A | ★ 4.52 |
| Revenue | ★ $8,726,100,000.00 | $1,403,665,000.00 |
| Revenue This Year | $4.71 | $14.34 |
| Revenue Next Year | $1.39 | $13.71 |
| P/E Ratio | ★ N/A | $71.73 |
| Revenue Growth | 6.69 | ★ 17.50 |
| 52 Week Low | $88.25 | $221.26 |
| 52 Week High | $119.39 | $362.41 |
| Indicator | SJM | PEN |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 35.58 |
| Support Level | $94.18 | $302.19 |
| Resistance Level | $98.96 | $335.61 |
| Average True Range (ATR) | 2.10 | 2.66 |
| MACD | 0.53 | -0.40 |
| Stochastic Oscillator | 61.17 | 5.82 |
J.M. Smucker is a packaged food company that primarily sells through the US retail channel (73% of fiscal 2025 revenue came through its retail pet foods, coffee, and frozen handheld/spreads segments), with the remaining share consisting of sweet baked snacks (through the Hostess acquisition) and international (primarily Canada). Retail coffee is its largest category (32% of sales) with brands Folgers and Dunkin'. Pet foods (19% of sales) holds leading brands like Milk-Bone and Meow Mix. Of its remaining, approximately 22% comes from frozen handhelds and spreads, through brands Jif, Smucker's, and Uncrustables. The company acquired Hostess Brands in fiscal 2024 to boost its snack and convenience store presence.
Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.